(Q40488602)

21 September 2017

title

Rational design of Salmonella-based vaccination strategies (English)

1 reference

21 September 2017

Simone Spreng

1

1 reference

21 September 2017

Guido Dietrich

series ordinal

2

1 reference

21 September 2017

Gerald Weidinger

series ordinal

3

1 reference

21 September 2017

publication date

1 February 2006

1 reference

21 September 2017

1 reference

21 September 2017

volume

38

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

133-143

1 reference

The mucosal immune system: from fundamental concepts to vaccine development

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Recent advances with recombinant bacterial vaccine vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Experience with registered mucosal vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Can needle-free administration of vaccines become the norm in global immunization?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Live oral vaccines against cholera: an update.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Isolation and Characterization of Gal E Mutant Ty 21a of Salmonella typhi: A Candidate Strain for a Live, Oral Typhoid Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Vaccination against enteric pathogens: from science to vaccine trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Oral immunization using live attenuated Salmonella spp. as carriers of foreign antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

The molecular mechanisms of severe typhoid fever.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Multi-drug resistant typhoid: a global problem.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Studies on infection and immunity in experimental typhoid fever. I. Typhoid fever in chimpanzees orally infected with Salmonella typhosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Vaccination for control of Salmonella in poultry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Experimental Salmonella typhi infection in the domestic pig, Sus scrofa domestica

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

The route of enteric infection in normal mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

The dissemination of Salmonella typhi, S. paratyphi A and S. paratyphi B through the organs of the white mouse by oral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Macrophage NRAMP1 and its role in resistance to microbial infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Typhoid fever: pathogenesis and immunologic control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

A review of human salmonellosis: I. Infective dose.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Intestinal perforation in typhoid fever: a historical and state-of-the-art review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Bacteraemia in salmonellosis: a 15 year retrospective study from a regional infectious diseases unit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Exploiting the immune system: toward new vaccines against intracellular bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Virulence and vaccine potential of Salmonella typhimurium mutants deficient in the expression of the RpoS (sigma S) regulon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Characterization of CD8(+) effector T cell responses in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Clinical and immunological response to typhoid vaccination with parenteral or oral vaccines in two groups of 30 recruits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Intracellular bacteria as targets and carriers for vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trial. Chilean Typhoid Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Host-Salmonella interaction: human trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

A controlled field trial of live Salmonella typhi strain Ty 21a oral vaccine against typhoid: three-year results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S. typhi vaccines; effect of formulation on safety and immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

A comparison of immunogenicity and in vivo distribution of Salmonella enterica serovar Typhi and Typhimurium live vector vaccines delivered by mucosal routes in the murine model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Salmonella enterica serovar Typhi live vector vaccines delivered intranasally elicit regional and systemic specific CD8+ major histocompatibility class I-restricted cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Bacterial virulence, proinflammatory cytokines and host immunity: how to choose the appropriate Salmonella vaccine strain?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Regulation of host immune responses by modification of Salmonella virulence genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Salmonella typhimurium strains carrying independent mutations display similar virulence phenotypes yet are controlled by distinct host defense mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Induction of specific immune responses in the genital tract of women after oral or rectal immunization and rectal boosting with Salmonella typhi Ty 21a vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

In vitro and in vivo stability of recombinant plasmids in a vaccine strain of Salmonella enterica var. Typhimurium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Stabilization of recombinant avirulent vaccine strains in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Plasmid maintenance systems suitable for GMO-based bacterial vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Regulated antigen expression in live recombinant Salmonella enterica serovar Typhimurium strongly affects colonization capabilities and specific CD4(+)-T-cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Impact of intracellular location of and antigen display by intracellular bacteria: implications for vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Secretion of recombinant proteins by Gram-negative bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Bacterial surface display: trends and progress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Display of proteins on bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

The E. coli alpha-hemolysin secretion system and its use in vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Haemolysin A and listeriolysin--two vaccine delivery tools for the induction of cell-mediated immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

From evil to good: a cytolysin in vaccine development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Bacterial type III translocation: a unique mechanism for cytosolic display of heterologous antigens by attenuated Salmonella

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Delivery of epitopes by the Salmonella type III secretion system for vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Inverted pathogenicity: the use of pathogen-specific molecular mechanisms for prevention or therapy of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Comparison of the abilities of different attenuated Salmonella typhimurium strains to elicit humoral immune responses against a heterologous antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

Progress in vaccines against typhoid fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

7 January 2021

Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

7 January 2021

Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

7 January 2021

Levels of expression and immunogenicity of attenuated Salmonella enterica serovar typhimurium strains expressing Escherichia coli mutant heat-labile enterotoxin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

7 January 2021

A recombinant Salmonella typhimurium vaccine induces local immunity by four different routes of immunization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2005.09.012

7 January 2021

10.1016/J.YMETH.2005.09.012

Identifiers

DOI

1 reference

21 September 2017

1 reference